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INTRODUCTION
Radical prostatectomy (RP) is established as a one of the treatment options for the curative treatment of prostate cancer, approximately 30% of all patients by 5 years after RP suffer biochemical relapse, 1) defined as increasingly serum prostate-specific antigen (PSA) levels > 0.2 ng/ml. Radiation therapy (RT) is often recommended in the salvage setting for biochemical relapse after RP. 2, 3) For salvage RT, the American Society for Therapeutic Radiology and Oncology consensus guidelines have recommended the highest radiation dose that can be delivered with acceptable morbidity and suggested a minimum of 64 Gy at conventional dose fractionation. 4) Indeed, four retrospective studies on salvage RT
showed that doses > 64 Gy provide improved biochemical control compared with lower doses. [5] [6] [7] [8] Moreover, recent analysis has shown that intensity-modulated radiotherapy (IMRT) to 75 Gy offers very good 5-year biochemical control. 9) However, dose escalation is associated with greater risk of toxicity if a greater volume of rectal wall is treated to moderate to high dose levels. The definition of the clinical target volume (CTV) in a setting of salvage RT after RP has just been presented in 2007 or 2008. 2, 10) Thus, to our knowledge, very few studies still have adequately examined the analysis of the dose-volume histograms (DVHs) on salvage RT after RP. 11) In order to generate adequate dosimetric data on salvage RT after RP, we created RT plans with threedimensional conformal radiotherapy (3D-CRT) for patients previously received salvage RT after RP and conducted a pilot comparison of 3D-CRT plans using the parameters of the maximum and mean doses received by organs at risk (OAR), target coverage, dose homogeneity for the planning target volume (PTV). In addition, we simulated whether dose escalation is possible with the "most adequate" 3D-CRT technique.
MATERIALS AND METHODS

Patients and radiation treatment outline
This study included consecutive 10 patients underwent salvage RT between 2005 and 2008 for biochemical relapse of prostate cancer initially treated with RP. All patients were immobilized in a supine position with computed tomography (CT) scans with a 5-mm slice thickness. All target volumes and normal structures were contoured on a FOCAL workstation (CMS, St Louis, USA). The CT images and structure sets were transferred to XiO (CMS, St Louis, USA), and all patients were planned using Xio. Treatment was delivered with 10-MV photons of a Varian linear accelerator (CLINAC 21EX; Varian Medical Systems). The prescribed radiation dose was 64 Gy in 32 fractions at the isocenter (ICRU prescription point).
The CTV was the prostate bed, which encompassed the prostatic and seminal vesicle bed, the bladder neck, the urethral anastomosis, and the proximal penile bulb, and the whole pelvis was not included for the CTV. Details followed the consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group.
2) The PTV included the CTV with a 6-mm margin in all directions. An 8-mm margin was added between the PTV and the field edge for penumbra to provide adequate coverage of the PTV. Normal structures included the rectum, the bladder, and the femoral head. The rectum was contoured as a solid organ extending from the level of ischial tuberosities corresponding to just above the anal verge up to the sigmoid flexure. The bladder was contoured as a whole organ including the cavity. Femoral heads were also contoured for each patient. Planning organs at risk volumes were not created. DVHs for the CTV, the PTV, the rectum, the bladder, and the femoral heads were computed. Percentage of the volume of the rectum that receives 40 Gy (VR 40 ), 50 Gy and 60 Gy (VR 50 and VR 60 ), percentage of the volume of the bladder that receives 40 Gy, 50 Gy and 60 Gy (VB 40 , VB 50 , and VB 60 ), the maximum dose of the left femoral head (DF max ), and the doses given to 95% of the PTV (DPTV 95 ) were calculated. In addition, the dose delivered to a 1%, 5%, and 10% volume of the rectum were also calculated (DR 1% , DR 5% , and DR 10% ). The doses to the right femoral head were omitted to describe because these were similar to the left data.
Beam arrangement of 3D-CRT planning
Four coplanar 3D-CRT techniques were planned. The first technique consisted of anterior-posterior, posterior-anterior, and two-lateral fields with multileaf collimators (MLCs) (4F-RT).
12) The second consisted of dynamic conformal arc 360° wide with dynamic MLCs (DCAT).
13) The third consisted of four-oblique conformal fields (RAO 50°, LAO 310°, RPO 130°, and LPO 230°) combined with two-lateral conformal fields (6F-RT).
14) The fourth consisted of DCAT of 40 Gy and boost DCAT with rectum hollow-out technique of 20 Gy (DCAT-HO). The techniques for treatment planning of dynamic conformal arc radiotherapy with rectum hollow-out technique (DCAT-HO) have been described in Fig. 1 . Dose distributions for patients of receiving total doses of 64 Gy with 4F-RT (upper left), with DCAT (upper right), with DCAT-HO (left below), and with 6F-RT (right below). Abbreviations: 4F-RT, conformal anterior-posterior, posterior-anterior, and two-lateral field radiotherapy; DCAT, dynamic conformal arc radiotherapy; DCAT-HO, dynamic conformal arc radiotherapy with rectum hollow-out technique; 6F-RT, conformal oblique combined two-lateral conformal field radiotherapy. detail in our previous report.
15 ) The superposition dose calculation algorithm was used.
16) The goal of the 3D-CRT planning was to provide adequate coverage of the PTV [a PTV within the International Commission on Radiation Units and Measurements (ICRU) limits (i.e. -5%: +7%)] 17) and deliver a dose distribution as homogeneous as possible within the PTV while obtaining a satisfactory sparing of OAR. Figure 1 demonstrates the representative dose distribution for each treatment plan (Fig. 1) .
Plan comparison criteria and statistical analysis
To our knowledge, no study still has examined the correlation between the rectal dose-volume data and late rectal toxicity on salvage RT after RP. Therefore, based on the several reports regarding radical RT at 70 Gy or higher of prescription dose for prostate cancer, [18] [19] [20] [21] we assumed a threshold as the benchmark to keep below frequency of Grade 2 or worse rectal toxicity 5% in this study, and we had an assumption that the optimal dose-volume constraints for the rectum consisted of VR40 < 65%, VR50 < 50%, VR60 < 35%, VR65 < 25%, VR70 < 15%. In the same way, based on the reports of several investigators, [22] [23] [24] we established that the optimal dose-volume constraints for the bladder consisted of VB60 < 45%, VB65 < 35%, VB70 < 30%. As for the femoral heads, we considered that no more than 10% of the femoral head should receive a dose higher than 52 Gy. 25) The treatment plan comparison metrics were compared using the following criteria: Dmin, Dmax, D95%, V95%, homogeneity index (HI), 26) VR40, VR50, VR60, VB40, VB50, VB60, and the maximum and mean dose for the rectum, the bladder, and the left femoral head. PTV coverage was assessed by comparing the minimum and maximum doses to the PTV (D min and D max , respectively), D 95% and the percentage of the PTV covered by at least 95% of the prescribed dose (V 95% ). Dose homogeneity in the target volumes was quantified by the HI. The HI is defined as the highest dose delivered to a 5% volume of the PTV (D 5% ) minus the dose delivered to 95% of the PTV (D 95% ) divided by the mean dose (D mean ) of the PTV. Smaller values of the HI correspond to a more homogenous irradiation of the target volume. A value of 0 corresponds to absolute homogeneity of dose within the target. To assess normal tissue sparing, the mean total dose, the maximum dose (Dmax and Dmean, respectively), VR40, VR50, VR60, VB40, VB50, and VB60 were used. Analyses were performed using a Student's t test to determine if there was a significant difference in any of the parameters examined. Differences were considered statistically significant at p < 0.05.
RESULTS
Dose-volume parameters for PTV
The Dmean, Dmin, Dmax, D95%, V95%, and the HI for the PTV in each treatment plan are listed in Table 1 . The Dmean for the PTV had no significant difference between 4F-RT technique and three compared 3D-CRT techniques. The Dmin, Dmax, V95%, and the HI for DCAT were significantly superior to those for 4F-RT. The Dmax, D95%, and the HI for DCAT-HO were significantly inferior to those for 4F-RT. All parameters Abbreviations: 3D-CRT, three-dimensional conformal radiotherapy; PTV, planning target volume; 4F-RT, conformal anterior-posterior, posterior-anterior, and two-lateral field radiotherapy; DCAT, dynamic conformal arc radiotherapy; DCAT-HO, dynamic conformal arc radiotherapy with rectum hollow-out technique; 6F-RT, conformal oblique combined two-lateral conformal field radiotherapy; Dmean, mean dose; Dmin, minimum dose; Dmax, maximum dose; D95%, dose to 95% volume of PTV; V95%, percentage of the volume of PTV that receives at least 95% of the prescribed dose; HI, homogeneity index. Values are mean ± standard deviation. *means statistically significant.
for the PTV had no significant difference between 4F-RT technique and 6F-RT technique. Thus, the results of target coverage and dose homogeneity for the PTV were summarized as follows; 4F-RT and 6F-RT were equivalent in target coverage and dose homogeneity, and DCAT were significantly superior to the parameters of target coverage and dose homogeneity for 4F-RT and 6F-RT. The parameters of target coverage and dose homogeneity for DCAT-HO were significantly inferior to those for other three techniques, but those were considered to be clinically tolerable.
Dose-volume histograms and dose-volume parameters for rectum
The comparison of 4F-RT technique and three different 3D-CRT techniques is demonstrated in Table 2 . According to Fig. 1 and Table 2 , DCAT-HO spared the rectal volume exposed to 60 Gy (VR60) compared with three other 3D-CRT, although the difference of VR60 was not significant between 4F-RT and DCAT-HO. The dose delivered to a 1%, 5%, and 10% volume of the rectum (DR1%, DR5%, and DR10%) for DCAT-HO were significantly lower than those for 4F-RT. However, the rectal volume exposed to the intermediate dose (VR40) for DCAT-HO was significantly larger than that of 4F-RT. All parameters for the rectum except DR 10% had no significant difference between 4F-RT technique and 6F-RT technique, and DR 10% for 6F-RT was significantly higher than that for 4F-RT. On the other hand, VR 40 , VR 50 , and VR 60 of DCAT did not meet a requirement for criteria. Thus, the results of rectum sparing were summarized as follows; 4F-RT and 6F-RT were almost equivalent in rectum sparing, and DCAT were significantly inferior to other three techniques. The rectum sparing at the high dose area for DCAT-HO was the most superior to those for other three techniques, but that of the intermediate dose (40 Gy) for DCAT-HO were significantly inferior to that for 4F-RT.
Dose-volume histograms and dose-volume parameters for bladder and femoral heads
The DBmean, DBmax, and VB40 to VB60 in each treatment plan are shown in Table 3 . The DBmean and VB40 to VB60 had no significant difference between 4F-RT technique and three compared 3D-CRT techniques, although the DBmean and VB40 to VB60 for DCAT and DCAT-HO were slightly inferior to those for other two techniques. DBmax for DCAT was significantly lower than that for 4F-RT. All four 3D-CRT techniques met criteria of bladder in this study.
The DFmean and DFmax in each treatment plan are also shown in Table 3 . DCAT and DCAT-HO significantly Abbreviations: 3D-CRT, three-dimensional conformal radiotherapy; 4F-RT, conformal anterior-posterior, posterior-anterior, and two-lateral field radiotherapy; DCAT, dynamic conformal arc radiotherapy; DCAT-HO, dynamic conformal arc radiotherapy with rectum hollow-out technique; 6F-RT, conformal oblique combined two-lateral conformal field radiotherapy; Dmean, mean dose; Dmax, maximum dose; VR40-60, percentage of the volume of the rectum that receives at least 40-60 Gy, respectively. DR1-10%, dose delivered to a 1%, 5%, and 10% volume of the rectum, respectively. Values are mean ± standard deviation. *means statistically significant. † means deviation of criteria in this study.
reduced DF mean and DF max compared with 4F-RT. DF max of 6F-RT techniques were significantly higher than that of 4F-RT technique. Apparently, four 3D-CRT techniques met criteria of femoral heads in this study.
Simulation of dose escalation using most adequate 3D-CRT technique
The rectum sparing at the high dose area for DCAT-HO (DR 1% , DR 5% , and DR 10% ) was the most superior to those Abbreviations: 3D-CRT, three-dimensional conformal radiotherapy; 4F-RT, conformal anterior-posterior, posterior-anterior, and two-lateral field radiotherapy; DCAT, dynamic conformal arc radiotherapy; DCAT-HO, dynamic conformal arc radiotherapy with rectum hollow-out technique; 6F-RT, conformal oblique combined two-lateral conformal field radiotherapy; Dmean, mean dose; Dmax, maximum dose; VR40-60, percentage of the volume of the rectum that receives at least 40-60 Gy, respectively. Values are mean ± standard deviation. *means statistically significant. 27 ) Therefore, we considered that DCAT-HO has potential as the simulation of dose escalation and simulated whether dose escalation is possible with DCAT-HO technique. The changes of rectum and bladder dose-volume parameters by the simulation of dose escalation using DACT-HO technique are demonstrated in Table  4 . The simulation of dose escalation to 72 Gy using DACT-HO technique showed small increases of irradiated rectal and bladder volumes in the range of 40 to 60 Gy. However, in the simulation of dose escalation to 72 Gy, VR65 and VR70 were markedly increased. In the simulation of dose escalation to 72 Gy, VR60, VR65, and VB65 exceeded the optimal dose-volume constraints of 35%, 25%, and 35%, respectively.
DISCUSSION
The rectum sparing at the high dose area for DCAT-HO (DR1%, DR5%, and DR10%) was the most superior to those for other three techniques with acceptable PTV coverage and dose homogeneity and tolerable bladder exposure, although the rectal volume exposed to the intermediate dose for DCAT-HO was significantly larger than that of 4F-RT. DACT-HO technique did not significantly increase V40 to V60 of bladder compared with three other 3D-CRT techniques. We think that on the DVHs the area under the average percent volume for the rectal wall of patients after RP was relatively higher than those of patients without RP, because the CTV in a setting of salvage RT after RP potentially contains relatively wide range of the space around the rectum. However, our study indicated that DCAT-HO was feasible for dose escalation to 70 Gy in a setting of salvage RT after RP. Recently, some studies have reported dose escalation with IMRT for biochemical relapse after RP. 9, 11) However, DCAT-HO needs less labor and cost for planning and verification compared to IMRT because an inverse-planning approach is not used with this technique. 15) There was one limitation to this study. That was no dose-volume constraints of OAR on salvage RT after RP. Therefore, we had no other choice of using the benchmark based on the reports regarding radical RT. [18] [19] [20] [21] Thus, although we confirmed that DCAT-HO could be feasible for dose escalation to 70 Gy in a setting of salvage RT after RP on this simulation study, an application of this result require a little attention on the clinical use.
On the other hand, there is one issue that should be solved. That is, the optimal total dose for salvage RT after RP has not been proven. A 1-cm 3 tumor contains ~ 10 9 cells and produces a PSA level of about 3.5 ng/ml; 28) therefore, a tumor producing a PSA level of 0.20 ng/ml will still contain about 10 7 -10 8 cells and a tumor volume will be 0.01-0.1-cm 3 , so that should be considered microscopic. To our knowledge, four retrospective studies showed that doses > 64 Gy provide improved biochemical control compared with lower doses. [5] [6] [7] [8] However, in three of four studies a median pre-RT PSA value was high level of approximately 0.7-1.4 ng/ml. [5] [6] [7] A recent analysis has shown that salvage RT to 70 Gy achieved superior 6-year bNED compared with 60 Gy (58% vs. 25%, p = 0.012). 8) However, in this study pre-RT PSA value were different between each dose group (0.90 ng/ ml in 60 Gy group, 0.45 ng/ml in 70 Gy group), although high dose was an independent factor for bNED on multivariate analysis. 8) When a rising PSA results from local recurrence and patients receive salvage RT at PSA levels of 0.20-0.50 ng/ml or less, we wonder why such high dose of 70 Gy seem to be required for microscopic disease. On the other hand, in our previous study RT dose ≥ 60 Gy improved bNED significantly. 29) Our data suggested that salvage RT with higher doses of 60 Gy may improves potentially biochemical outcome even in a setting of pre-RT PSA value < 0.50 ng/ml. Stephenson' and Quero' studies 30, 31) have provided evidence that RT should be given earlier after biochemical relapse. Therefore, a randomized trial in a setting of pre-RT PSA value < 0.50 ng/ml comparing two dose groups, for example 60 Gy vs. 70 Gy, would be capable of addressing this issue.
In conclusion, DCAT-HO was considered to be the one of the appropriate techniques for salvage RT after RP because DCAT-HO reduced the dose delivered to a 1%, 5%, and 10% volume of the rectum compared with other three techniques with acceptable PTV coverage and dose homogeneity and tolerable bladder exposure. DCAT-HO was considered to be one of the most appropriate techniques in 3D-CRT if dose escalation to 70 Gy might be needed in a setting of salvage RT after RP in the future. As the optimal total dose for salvage RT after RP has not been proven, especially in a setting of pre-RT PSA value < 0.50 ng/ml, a randomized trial in a setting of pre-RT PSA value < 0.50 ng/ml comparing 60 Gy vs. 70 Gy, would be capable of addressing this issue, using DCAT-HO.
